San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, 1859 Inc. is raising $9,713,740.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Devon Cayer played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About 1859 Inc.
1859 develops benchtop instrument designed to discover new medicines. The companys instrument helps in creating new medicine, enabling scientists to parallelize the discovery of new medicines faster, cheaper, and more efficiently.

To learn more about 1859 Inc., visit http://www.eighteenfiftynine.com/

Contact:
Devon Cayer, Chief Executive Officer
562-522-2882
https://www.linkedin.com/in/devon-cayer-8669611a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved